Please wait...
About This Project
We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.
Browse Other Projects on Experiment
Related Projects
Targeted Drug Delivery by using Magnetic Nanoparticles
What if we could use a novel approach for delivering currently injectable drugs to the body without syringes...
How does taking Ritalin affect depersonalization-derealization disorder patients?
We are investigating Ritalin's role in alleviating symptoms of depersonalization-derealization (DPDR) disorder...
Can low carbohydrate ketogenic diets inhibit cancers?
Insulin is a hormone which supports growth of normal cells, but also of cancers. A very low carbohydrate...